Scientists target human trials for new Ebola vaccine 'within months'

Moderna and other groups get $60m to develop Ebola vaccine

CEPI funds Moderna, Oxford, IAVI with $60M for Ebola Bundibugyo trials in two months, addressing 282+ DRC cases. mRNA platform reuse compresses vaccine cycles from years to months—a governance model for infrastructure agility under crisis.